Dimethyl fumarate Accord 欧盟 - 德文 - EMA (European Medicines Agency)

dimethyl fumarate accord

accord healthcare s.l.u. - dimethylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunsuppressiva - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).